Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.

Ribeiro, Henrique B; Rodés-Cabau, Josep; Blanke, Philipp; Leipsic, Jonathon; Kwan Park, Jong; Bapat, Vinayak; Makkar, Raj; Simonato, Matheus; Barbanti, Marco; Schofer, Joachim; Bleiziffer, Sabine; Latib, Azeem; Hildick-Smith, David; Presbitero, Patrizia; Windecker, Stephan; Napodano, Massimo; Cerillo, Alfredo G; Abdel-Wahab, Mohamed; Tchetche, Didier; Fiorina, Claudia; Sinning, Jan-Malte; Cohen, Mauricio G; Guerrero, Mayra E; Whisenant, Brian; Nietlispach, Fabian; Palma, José Honório; Nombela-Franco, Luis; de Weger, Arend; Kass, Malek; Sandoli de Brito, Fabio; Lemos, Pedro A; Kornowski, Ran; Webb, John; Dvir, Danny.
Eur Heart J; 39(8): 687-695, 2018 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-29020413

AIMS:

There are limited data on coronary obstruction following transcatheter valve-in-valve (ViV) implantation inside failed aortic bioprostheses. The objectives of this study were to determine the incidence, predictors, and clinical outcomes of coronary obstruction in transcatheter ViV procedures.

METHODS AND RESULTS:

A total of 1612 aortic procedures from the Valve-in-Valve International Data (VIVID) Registry were evaluated. Data were subject to centralized blinded corelab computed tomography (CT) analysis in a subset of patients. The virtual transcatheter valve to coronary ostium distance (VTC) was determined. A total of 37 patients (2.3%) had clinically evident coronary obstruction. Baseline clinical characteristics in the coronary obstruction patients were similar to controls. Coronary obstruction was more common in stented bioprostheses with externally mounted leaflets or stentless bioprostheses than in stented with internally mounted leaflets bioprostheses (6.1% vs. 3.7% vs. 0.8%, respectively; P < 0.001). CT measurements were obtained in 20 (54%) and 90 (5.4%) of patients with and without coronary obstruction, respectively. VTC distance was shorter in coronary obstruction patients in relation to controls (3.24 ± 2.22 vs. 6.30 ± 2.34, respectively; P < 0.001). Using multivariable analysis, the use of a stentless or stented bioprosthesis with externally mounted leaflets [odds ratio (OR): 7.67; 95% confidence interval (CI): 3.14-18.7; P < 0.001] associated with coronary obstruction for the global population. In a second model with CT data, a shorter VTC distance predicted this complication (OR: 0.22 per 1 mm increase; 95% CI: 0.09-0.51; P < 0.001), with an optimal cut-off level of 4 mm (area under the curve: 0.943; P < 0.001). Coronary obstruction was associated with a high 30-day mortality (52.9% vs. 3.9% in the controls, respectively; P < 0.001).

CONCLUSION:

Coronary obstruction following aortic ViV procedures is a life-threatening complication that occurred more frequently in patients with prior stentless or stented bioprostheses with externally mounted leaflets and in those with a short VTC.
Selo DaSilva